vs
HALOZYME THERAPEUTICS, INC.（HALO）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是HALOZYME THERAPEUTICS, INC.的1.5倍（$663.0M vs $451.8M），Reddit, Inc.净利率更高（30.8% vs -31.3%，领先62.1%），Reddit, Inc.同比增速更快（69.0% vs 51.6%），Reddit, Inc.自由现金流更多（$311.0M vs $217.6M），过去两年Reddit, Inc.的营收复合增速更高（53.6% vs 51.9%）
Halozyme Therapeutics是一家美国生物技术企业，专注于肿瘤领域创新疗法研发，核心管线均针对肿瘤微环境进行靶向干预，致力于为全球癌症患者提供更安全高效的治疗选择。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
HALO vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.5倍
$451.8M
营收增速更快
RDDT
高出17.4%
51.6%
净利率更高
RDDT
高出62.1%
-31.3%
自由现金流更多
RDDT
多$93.4M
$217.6M
两年增速更快
RDDT
近两年复合增速
51.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $451.8M | $663.0M |
| 净利润 | $-141.6M | $204.0M |
| 毛利率 | 82.6% | 100.0% |
| 营业利润率 | -20.6% | 0.0% |
| 净利率 | -31.3% | 30.8% |
| 营收同比 | 51.6% | 69.0% |
| 净利润同比 | -203.3% | 680.0% |
| 每股收益（稀释后） | $-1.13 | $1.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HALORDDT
| Q1 26 | — | $663.0M | ||
| Q4 25 | $451.8M | $725.6M | ||
| Q3 25 | $354.3M | $584.9M | ||
| Q2 25 | $325.7M | $499.6M | ||
| Q1 25 | $264.9M | $392.4M | ||
| Q4 24 | $298.0M | $427.7M | ||
| Q3 24 | $290.1M | $348.4M | ||
| Q2 24 | $231.4M | $281.2M |
净利润HALORDDT
| Q1 26 | — | $204.0M | ||
| Q4 25 | $-141.6M | $251.6M | ||
| Q3 25 | $175.2M | $162.7M | ||
| Q2 25 | $165.2M | $89.3M | ||
| Q1 25 | $118.1M | $26.2M | ||
| Q4 24 | $137.0M | $71.0M | ||
| Q3 24 | $137.0M | $29.9M | ||
| Q2 24 | $93.2M | $-10.1M |
毛利率HALORDDT
| Q1 26 | — | 100.0% | ||
| Q4 25 | 82.6% | 91.9% | ||
| Q3 25 | 84.4% | 91.0% | ||
| Q2 25 | 85.8% | 90.8% | ||
| Q1 25 | 81.7% | 90.5% | ||
| Q4 24 | 85.9% | 92.6% | ||
| Q3 24 | 83.0% | 90.1% | ||
| Q2 24 | 82.9% | 89.5% |
营业利润率HALORDDT
| Q1 26 | — | 0.0% | ||
| Q4 25 | -20.6% | 31.9% | ||
| Q3 25 | 61.5% | 23.7% | ||
| Q2 25 | 62.2% | 13.6% | ||
| Q1 25 | 53.4% | 1.0% | ||
| Q4 24 | 58.9% | 12.4% | ||
| Q3 24 | 56.3% | 2.0% | ||
| Q2 24 | 50.7% | -11.0% |
净利率HALORDDT
| Q1 26 | — | 30.8% | ||
| Q4 25 | -31.3% | 34.7% | ||
| Q3 25 | 49.5% | 27.8% | ||
| Q2 25 | 50.7% | 17.9% | ||
| Q1 25 | 44.6% | 6.7% | ||
| Q4 24 | 46.0% | 16.6% | ||
| Q3 24 | 47.2% | 8.6% | ||
| Q2 24 | 40.3% | -3.6% |
每股收益（稀释后）HALORDDT
| Q1 26 | — | $1.01 | ||
| Q4 25 | $-1.13 | $1.24 | ||
| Q3 25 | $1.43 | $0.80 | ||
| Q2 25 | $1.33 | $0.45 | ||
| Q1 25 | $0.93 | $0.13 | ||
| Q4 24 | $1.06 | $4.76 | ||
| Q3 24 | $1.05 | $0.16 | ||
| Q2 24 | $0.72 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.8M | $1.4B |
| 总债务越低越好 | $2.1B | — |
| 股东权益账面价值 | $48.8M | $3.2B |
| 总资产 | $2.5B | $3.5B |
| 负债/权益比越低杠杆越低 | 43.89× | — |
8季度趋势，按日历期对齐
现金及短期投资HALORDDT
| Q1 26 | — | $1.4B | ||
| Q4 25 | $133.8M | $953.6M | ||
| Q3 25 | $419.7M | $911.7M | ||
| Q2 25 | $61.9M | $734.1M | ||
| Q1 25 | $176.3M | $635.7M | ||
| Q4 24 | $115.8M | $562.1M | ||
| Q3 24 | $154.3M | $515.9M | ||
| Q2 24 | $187.9M | $468.0M |
总债务HALORDDT
| Q1 26 | — | — | ||
| Q4 25 | $2.1B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — |
股东权益HALORDDT
| Q1 26 | — | $3.2B | ||
| Q4 25 | $48.8M | $2.9B | ||
| Q3 25 | $503.9M | $2.6B | ||
| Q2 25 | $332.7M | $2.4B | ||
| Q1 25 | $482.3M | $2.2B | ||
| Q4 24 | $363.8M | $2.1B | ||
| Q3 24 | $452.7M | $2.0B | ||
| Q2 24 | $289.4M | $1.9B |
总资产HALORDDT
| Q1 26 | — | $3.5B | ||
| Q4 25 | $2.5B | $3.2B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.2B | $2.4B | ||
| Q4 24 | $2.1B | $2.3B | ||
| Q3 24 | $2.1B | $2.2B | ||
| Q2 24 | $2.0B | $2.1B |
负债/权益比HALORDDT
| Q1 26 | — | — | ||
| Q4 25 | 43.89× | — | ||
| Q3 25 | 3.00× | — | ||
| Q2 25 | 4.54× | — | ||
| Q1 25 | 3.13× | — | ||
| Q4 24 | 4.14× | — | ||
| Q3 24 | 3.32× | — | ||
| Q2 24 | 5.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $219.0M | — |
| 自由现金流经营现金流 - 资本支出 | $217.6M | $311.0M |
| 自由现金流率自由现金流/营收 | 48.2% | 46.9% |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $644.6M | $868.6M |
8季度趋势，按日历期对齐
经营现金流HALORDDT
| Q1 26 | — | — | ||
| Q4 25 | $219.0M | $266.8M | ||
| Q3 25 | $178.6M | $185.2M | ||
| Q2 25 | $99.7M | $111.3M | ||
| Q1 25 | $154.2M | $127.6M | ||
| Q4 24 | $178.5M | $90.0M | ||
| Q3 24 | $115.4M | $71.6M | ||
| Q2 24 | $55.8M | $28.4M |
自由现金流HALORDDT
| Q1 26 | — | $311.0M | ||
| Q4 25 | $217.6M | $263.6M | ||
| Q3 25 | $175.6M | $183.1M | ||
| Q2 25 | $98.1M | $110.8M | ||
| Q1 25 | $153.3M | $126.6M | ||
| Q4 24 | $175.4M | $89.2M | ||
| Q3 24 | $113.9M | $70.3M | ||
| Q2 24 | $53.2M | $27.2M |
自由现金流率HALORDDT
| Q1 26 | — | 46.9% | ||
| Q4 25 | 48.2% | 36.3% | ||
| Q3 25 | 49.6% | 31.3% | ||
| Q2 25 | 30.1% | 22.2% | ||
| Q1 25 | 57.9% | 32.3% | ||
| Q4 24 | 58.9% | 20.8% | ||
| Q3 24 | 39.3% | 20.2% | ||
| Q2 24 | 23.0% | 9.7% |
资本支出强度HALORDDT
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.4% | ||
| Q3 25 | 0.9% | 0.4% | ||
| Q2 25 | 0.5% | 0.1% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 1.0% | 0.2% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 1.1% | 0.4% |
现金转化率HALORDDT
| Q1 26 | — | — | ||
| Q4 25 | — | 1.06× | ||
| Q3 25 | 1.02× | 1.14× | ||
| Q2 25 | 0.60× | 1.25× | ||
| Q1 25 | 1.31× | 4.88× | ||
| Q4 24 | 1.30× | 1.27× | ||
| Q3 24 | 0.84× | 2.40× | ||
| Q2 24 | 0.60× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HALO
| Royalty | $258.0M | 57% |
| Products | $122.7M | 27% |
| Proprietary Products Sales | $59.6M | 13% |
| Device Partnered Products | $12.9M | 3% |
RDDT
暂无分部数据
